Oncology & Infusion Therapy

Requires Standards 1–7 verified first

4 criteria

ALL YES Standard likely met. ANY PARTIAL Improvement plan required. ANY NO Blocks accreditation until resolved.

REFERENCES

1. [57] Established hazardous drug handling standards, recognized in various forms across many countries' pharmacy and occupational safety guidance, require defined personal protective equipment, engineering controls, and procedures for the receipt, storage, compounding, administration, and disposal of hazardous drugs.

Hazardous drug exposure risk extends beyond the patient to every staff member who prepares, administers, or disposes of these medications, and the risks — including reproductive and long-term health effects from repeated exposure — are serious enough that international standards exist specifically to govern every stage of handling, not administration alone.

1 PPE is used correctly during administration but less consistently during preparation.

Every handling stage carries real exposure risk, not administration alone.

2 Engineering controls exist but staff weren't specifically trained on their correct use.

Correct equipment without correct training doesn't provide the intended protection.

3 Waste disposal follows the correct pathway for most hazardous drugs but not all categories on the hazardous list.

The full hazardous drug list is broader than chemotherapy alone, and each category carries the same real handling requirement.

Week 1 Review current handling practice against required PPE, engineering controls, and disposal standards.

Week 2 Address any gaps in PPE use or engineering controls.

Week 3 Establish or verify a compliant hazardous waste disposal pathway.

Ongoing Train staff periodically and audit handling practice.

Observe preparation and disposal, not only administration.

Attention often concentrates on administration, leaving earlier and later stages less consistently observed.

Ask to see the actual hazardous waste disposal pathway and its documentation.

A specific, verifiable pathway is the real evidence of compliant disposal.

ALL YES Standard likely met. ANY PARTIAL Improvement plan required. ANY NO Blocks accreditation until resolved.

REFERENCES

1. [58] Neuss MN, Gilmore TR, Belderson KM, Billett AL, Conti-Kalchik T, Harvey BE, et al. 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology. J Oncol Pract. 2016;12(12):1262-1271 — mandates independent verification by two qualified individuals of chemotherapy drug, dose, route, and infusion rate prior to administration.

Chemotherapy dosing errors carry genuinely serious consequences, and a single point of verification means a single point of failure — the independent double-check exists specifically because two people forming separate judgements catch errors that one person, however careful, can miss.

1 Independent verification is strong for new regimens but becomes routine and less rigorous for familiar ones.

Familiarity can quietly erode the genuine independence the check depends on.

2 Verification happens together, side by side, rather than separately before comparing.

Checking together risks one person's read of the order influencing the other's, undermining genuine independence.

3 Infusion rate verification is inconsistent compared to drug and dose verification.

An incorrect rate carries real risk distinct from an incorrect dose or drug.

Week 1 Review current verification practice for genuine independence between checkers.

Week 2 Retrain staff on separate, independent verification before comparing conclusions.

Week 3 Confirm the verification checklist covers drug, dose, route, and infusion rate together.

Ongoing Audit verification records and observe practice periodically.

Observe an actual double-check, watching specifically for separate, independent review.

Genuine independence is visible in practice in a way records alone cannot confirm.

Ask two different verifiers separately what they checked.

Consistent, specific answers from both reveal genuine independent verification.

ALL YES Standard likely met. ANY PARTIAL Improvement plan required. ANY NO Blocks accreditation until resolved.

REFERENCES

1. [59] Extravasation recognition and immediate management protocols, including agent-specific antidote availability, are established as a distinct and essential component of safe chemotherapy administration, separate from general infusion site monitoring.

Extravasation of a vesicant chemotherapy agent can cause severe, sometimes permanent tissue damage, and the difference between a manageable event and lasting harm often comes down to how quickly it's recognised and correctly managed, not the event itself.

1 Recognition training happened at hiring but hasn't been refreshed as new agents were introduced.

Training needs to stay current with the actual agents in use, not reflect an earlier point in time.

2 A protocol exists but doesn't specify agent-specific management steps.

Different vesicant agents may require different specific management approaches.

3 Antidote stock exists but expiry dates weren't recently verified.

Expired antidotes provide no real protection when actually needed.

Week 1 Review current extravasation training against the specific agents administered.

Week 2 Update or establish an agent-specific management protocol.

Week 3 Confirm on-site antidote stock and expiry dates for all vesicant agents used.

Ongoing Refresh training whenever new agents are introduced.

Ask about a specific agent used here, not extravasation in general.

Specificity reveals whether training genuinely reflects current practice.

Physically check antidote stock and expiry dates.

Physical verification is the only real evidence of genuine on-site availability.

ALL YES Standard likely met. ANY PARTIAL Improvement plan required. ANY NO Blocks accreditation until resolved.

REFERENCES

1. [60] Infusion reaction and anaphylaxis response protocols, including rehearsed drills rather than written policy alone, are identified as essential to safe ambulatory infusion practice given the narrow time window in which effective intervention determines patient outcome.

An infusion reaction can escalate to anaphylaxis within minutes, and a written protocol nobody has actually practiced is a poor substitute for a team that has rehearsed the actual sequence of what to do, in the actual space where infusions happen.

1 A drill was conducted once but hasn't been repeated since.

Rehearsed response capability fades over time without periodic repetition, particularly given staff turnover.

2 Emergency equipment is nearby but not genuinely at every point where infusions actually happen.

A reaction can occur at any infusion chair, and equipment needs to be immediately reachable from all of them.

3 Clinical staff know their role clearly but support staff present during infusions are less certain.

A reaction response often benefits from every present staff member knowing their part, not clinical staff alone.

Week 1 Assess current response readiness against genuine rehearsed practice, not policy review alone.

Week 2 Conduct an actual reaction response drill with all relevant staff.

Week 3 Verify emergency equipment is genuinely accessible from every infusion point.

Ongoing Repeat drills periodically, particularly after staff changes.

Ask for the date of the last actual drill, not the date the protocol was written.

A specific, recent drill date is the real evidence of rehearsed readiness.

Ask a support staff member, not just a nurse, about their role in a response.

This reveals whether readiness genuinely extends to everyone present, not only clinical staff.